VIR-5818
VIR-5818-V101
Phase 2 small_molecule active
Quick answer
VIR-5818 for Locally Advanced or Metastatic HER2-Expressing Cancers is a Phase 2 program (small_molecule) at Vir Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vir Biotechnology
- Indication
- Locally Advanced or Metastatic HER2-Expressing Cancers
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active